Trade Summary

4 days ago, Guyer Charles Greg, serving as EVP, Chief Technical Officer at Biomarin Pharmaceutical Inc (BMRN), sold 16,486 shares at $60.46 per share, for a total transaction value of $996,744.00. Following this transaction, Guyer Charles Greg now holds 79,953 shares of BMRN.

This sale represents a 17.00% decrease in Guyer Charles Greg's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 1 day after the trade was made.

Biomarin Pharmaceutical Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.